From: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
 | MAE | RMSE | AICa | BICa | QICa | Meanb | Absolute Difference |
---|---|---|---|---|---|---|---|
Linear regression | 0.1203 | 0.1680 | – | – | – | 0.7103 | 0.0047 |
Response mapping | 0.1191 | 0.1702 | – | – | – | 0.7057 | 0.0093 |
1 component ALDVMM | 0.1196 | 0.1696 | − 2302.11 | − 2164.82 | − 2289.01 | 0.7201 | 0.0051 |
2 component ALDVMM | 0.1173 | 0.1684 | − 2538.83 | −2164.82 | − 2515.96 | 0.7201 | 0.0051 |
3 component ALDVMM | 0.1172 | 0.1677 | − 2528.40 | − 2154.39 | − 2459.09 | 0.7171 | 0.0021 |
4 component ALDVMM | 0.1173 | 0.1675 | − 2673.51 | − 2168.59 | − 2629.49 | 0.7182 | 0.0032 |